Online citations, reference lists, and bibliographies.
← Back to Search

A Solid Colloidal Drug Delivery System For The Eye: Encapsulation Of Pilocarpin In Nanoparticles.

T. Harmia, P. Speiser, J. Kreuter
Published 1986 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The present study was undertaken in order to encapsulate pilocarpin into nanoparticles. Two principally different methods for manufacturing these particles were investigated. Firstly, pilocarpin was dissolved in an aqueous medium in which the polymerization was carried out, and secondly, the polymerizing monomer was kept saturated with the drug solution under acidic conditions resulting in an incorporation into the nanoparticles in an aqueous environment. The amount of pilocarpin that could be incorporated into the nanoparticles was found to be largely influenced by the temperature at which the nanoparticles were produced and by the stabilizers used. At low temperatures, up to 60 per cent of pilocarpin nitrate could be encapsulated into butylcyanoacrylate nanoparticles using emulsion polymerization techniques. Larger amounts of pilocarpin could not be incorporated because of the hydrophilicity of the salts of this drug. The physico-chemical characteristics of the nanoparticles are reported: the particle size and morphology were determined by scanning and transmission electron microscopy and photon correlation spectrometry. The average particle size was about 100 nm. The results obtained in this study show that photon correlation spectrometry is a suitable method for the sizing of nanoparticles.
This paper references
10.1159/000162849
The use of new polymethylmethacrylate adjuvants for split influenza vaccines.
J. Kreuter (1976)
10.1002/JPS.2600681215
Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum.
P. Couvreur (1979)
10.1002/POL.1970.110081007
Polymer colloids: Particle formation in nonmicellar systems
R. Fitch (1970)
10.1016/0378-5173(83)90113-8
Physicochemical characterization of polyacrylic nanoparticles
J. Kreuter (1983)
Evaluation of nanoparticles as drug-delivery systems. III: materials, stability, toxicity, possibilities of targeting, and use.
J. Kreuter (1983)
10.1002/JBM.820010103
Tissue adhesives and hemostasis-inducing compounds: the alkyl cyanocrylates.
F. Leonard (1967)
10.1016/0014-2964(80)90053-5
Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor.
F. Brasseur (1980)
10.1128/IAI.13.1.204-210.1976
New adjuvants on a polymethylmethacrylate base.
J. Kreuter (1976)
10.1002/JPS.2600590327
Optimal ferric hydroxamate method for determination of intact pilocarpine.
I. Gibbs (1970)
10.1111/J.2042-7158.1978.TB10709.X
DIFFUSION OF SMALL MOLECULES IN POLY‐N‐ALKYL CYANOACRYLATES
W. R. Vezin (1978)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.3929/ETHZ-A-000293592
Polyacrylic nanoparticles as controlled release drug delivery systems
D. Leu (1983)
10.1016/0014-5793(77)80717-5
Nanocapsules: A new type of lysosomotropic carrier
P. Couvreur (1977)
10.1002/PI.4980050606
The homogeneous nucleation of polymer colloids
R. Fitch (1973)



This paper is referenced by
10.1007/s12645-011-0013-9
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
Moutushy Mitra (2011)
10.1007/978-3-642-76084-6
Glaucoma Update IV
G. Krieglstein (1991)
10.1211/jpp.58.2.0004
Characterization of pilocarpine‐loaded chitosan/Carbopol nanoparticles
Huei-Jen Kao (2006)
10.1016/0169-409X(95)00017-2
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
10.3109/03639049509069263
METHOTREXATELOADED NANOPARTICLES: ANALYSIS OF DRUG CONTENT AND STUDY OF THE MATRIX STRUCTURE
M. I. Llovet (1995)
10.1007/978-1-4757-4175-9_13
Pharmacokinetics and Biopharmaceutical Aspects of Some Anti-Glaucoma Drugs
B. Plazonnet (1987)
10.1201/9781420006360-4
Characteristics of Polymers
M. Chanda (2006)
GELATIN NANOPARTICLE: PREPARATION, CHARACTERIZATION AND APPLICATION IN DRUG DELIVERY Kushagri Singh* and Abha Mishra School of Biochemical Engineering, Indian Institute of Technology, Banaras Hindu University, Uttar Pradesh, India ABSTRACT: Nanotechnology plays an important role in advanced biology
Kushagri Singh (2014)
10.1081/DDC-52073
Oral Bioadhesive Drug Delivery Systems
M. Bruschi (2005)
10.1163/156856207779116739
Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery
H. Lin (2007)
10.1201/B15642-8
Book Chapter 7: Therapeutic Applications and Targeted Delivery of Nanomedicines and Nanopharmaceutical Products.
H. M. Mansour (2013)
10.1023/B:PHAM.0000026432.75781.cb
Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity
A. M. de Campos (2004)
10.1101/628792
Preparation and in vitro release of fluorouracil polylactide glycolide-polyethylene glycol monomethyl ether nanoparticles
Anil Shumroni (2019)
10.4028/WWW.SCIENTIFIC.NET/AMR.1060.74
Preparation Process and Properties of Crosslinked Gelatin Beads for Drug Loading
Wiwat Pichayakorn (2014)
Dual Drug-Loaded Electrospun Nanofibres for the Treatment of Corneal Diseases
E. Tawfik (2019)
10.1002/9783527675821.CH04
MOFs in Pharmaceutical Technology
C. Tamames-Tabar (2014)
10.1016/j.drudis.2007.10.021
Nanotechnology in ocular drug delivery.
S. Sahoo (2008)
Surface Modification of Carboxyl-functionalized Polymeric Nanoparticles for Attachment of Targeting Peptides
G. Kasting (2009)
10.1007/978-1-4757-4175-9_11
Nanoparticles and Liposomes in Ophthalmic Drug Delivery
J. Kreuter (1987)
PROTEIN NANOPARTICLES: FUTURE OF DRUG DELIVERY SYSTEMS
Alok Mahor (2014)
10.3109/03639049609041987
Effect of polymerization coadjuvants on nanocapsule elaboration and triamcinolone entrapment
J. Valero (1996)
10.1016/j.neuint.2015.08.011
Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions
R. Sandhir (2015)
10.1101/636316
HA Nanocarriers Mediate HepG2 Vaccine Induction of hGM-CSF Gene Antitumor effect study
L. Robert (2019)
CHITOSAN LOADED MICROSPHERES AS AN OCULAR DELIVERY SYSTEM FOR ACYCLOVIR Research Article
J. Karthikeyan (2012)
10.2174/157015912804143513
Revolutionary Impact of Nanodrug Delivery on Neuroscience
R. Khanbabaie (2012)
10.1016/0378-5173(91)90128-B
Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles
M. Alonso (1991)
10.1016/S0169-409X(96)00483-8
Nanoparticle drug delivery system for restenosis
V. Labhasetwar (1997)
10.1016/0079-6700(89)90012-9
Synthetic polymers in modern pharmacy
W. J. Passl (1989)
10.1167/IOVS.05-0495
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.
Amalia Enríquez de Salamanca (2006)
10.3390/pharmaceutics12070604
Protein-Based Nanoparticles as Drug Delivery Systems
Seyoung Hong (2020)
10.1016/0378-5173(86)90053-0
Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles
T. Harmia (1986)
10.2147/IJN.S254792
Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
Song Kwon (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar